✦ LIBER ✦

Endocrine and clinical evaluation of 4-hydroxy-androstenedione in postmenopausal patients with advanced breast cancer (BC)

✍ Scribed by Scanni, A.; Farina, G.; Stankov, B.; Fraschini, F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical and endocrine effects of cyprot

✍ Willemse, P.H.B.; Dikkeschei, L.D.; Mulder, N.H.; Van Der Ploeg, E.; Sleijfer, D 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 490 KB

Clinical and endocrine effects of cyprot

✍ Willemse, PHB; Dikkeschei, LD; Mulder, NH 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 104 KB

702 - 4-hydroxyandrostenedione (4-OHA) a

✍ C.S. Gennatas; J. Psychogios; C. Dardoufas; N. Tsavaris; S. Athanasiadis 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 215 KB

4-HYDROXYANDROSTENEDIONE IN TREATMENT OF

✍ Coombes, R.Charles; Dowsett, Mitch; Goss, Paul; Gazet, J-C.; Brodie, Angela 📂 Article 📅 1984 🏛 The Lancet 🌐 English ⚖ 352 KB

Endocrinology and pharmacokinetics of or

✍ M. Dowsett; D. Cunningham; S. Nichols; A. Lal; S. Evans; A.M.H. brodle; S.L. Jef 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Target and reality of adjuvant endocrine

✍ Güth, U; Huang, D J; Schötzau, A; Zanetti-Dällenbach, R; Holzgreve, W; Bitzer, J 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 119 KB